摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[(2-Amino-4-pyridyl)oxy]-3-chloro-1H-1-indole | 417721-98-3

中文名称
——
中文别名
——
英文名称
5-[(2-Amino-4-pyridyl)oxy]-3-chloro-1H-1-indole
英文别名
5-((2-amino-pyridin-4-yl)oxy)-3-chloro-1H-1-indole;4-[(3-chloro-1H-indol-5-yl)oxy]pyridin-2-amine
5-[(2-Amino-4-pyridyl)oxy]-3-chloro-1H-1-indole化学式
CAS
417721-98-3
化学式
C13H10ClN3O
mdl
——
分子量
259.695
InChiKey
ZCLXWVCOPZHRAF-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.8
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    63.9
  • 氢给体数:
    2
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Nitrogen-Containing Aromatic Derivatives
    申请人:Funahashi Yasuhiro
    公开号:US20100197911A1
    公开(公告)日:2010-08-05
    Compounds represented by the following general formula: [wherein A g is an optionally substituted 5- to 14-membered heterocyclic group, etc.; X g is —O—, —S—, etc.; Y g is an optionally substituted C 6-14 aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and T g1 is a group represented by the following general formula: (wherein E g is a single bond or —N(R g2 )—, R g1 and R g2 each independently represent a hydrogen atom, an optionally substituted C 1-6 alkyl group, etc. and Z g represents a C 1-8 alkyl group, a C 3-8 alicyclic hydrocarbon group, a C 6-14 aryl group, etc.)], salts thereof or hydrates of the foregoing.
    以下是由下列通式表示的化合物:[其中Ag是可选取代的5-至14-成员杂环基团等;Xg是-O-,-S-等;Yg是可选取代的C6-14芳基团,可选取代的5-至14-成员杂环基团等;Tg1是由下列通式表示的基团:(其中Eg是单键或-N(Rg2)-,Rg1和Rg2各自独立地表示氢原子,可选取代的C1-6烷基团等;Zg表示C1-8烷基团,C3-8萜环碳氢基团,C6-14芳基团等)],其盐或上述化合物的水合物。
  • NITROGEN-CONTAINING AROMATIC DERIVATIVES
    申请人:FUNAHASHI Yasuhiro
    公开号:US20110118470A1
    公开(公告)日:2011-05-19
    Compounds represented by the following general formula: wherein A g is an optionally substituted 5- to 14-membered heterocyclic group, etc.; X g is —O—, —S—, etc.; Y g is an optionally substituted C 6-14 aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and T g1 is a group represented by the following general formula: (wherein E g is a single bond or —N(R g2 )—), R g1 and R g2 each independently represent a hydrogen atom, an optionally substituted C 1-6 alkyl group, etc. and Z g represents a C 1-8 alkyl group, a C 3-8 alicyclic hydrocarbon group, a C 6-14 aryl group, etc.), salts thereof or hydrates of the foregoing.
    以下通式所表示的化合物:其中Ag是可选取代的5-至14-成员杂环基团等;Xg是-O-,-S-等;Yg是可选取代的C6-14芳基团,可选取代的5-至14-成员杂环基团等;Tg1是以下通式所表示的基团:其中Eg为单键或-N(Rg2)-,Rg1和Rg2各自独立地表示氢原子,可选取代的C1-6烷基基团等,而Zg则表示C1-8烷基基团,C3-8萜烃环基团,C6-14芳基团等,其盐或以上化合物的水合物。
  • Nitrogen-containing aromatic heterocycles
    申请人:Eisai Co. Ltd.
    公开号:EP1506962A2
    公开(公告)日:2005-02-16
    Compounds represented by the following general formula: [wherein Ag is an optionally substituted 5- to 14-membered heterocyclic group, etc.; Xg is -O-, -S-, etc.; Yg is an optionally substituted C6-14 aryl group, an optionally substituted 5- to 14-membered heterocyclic group, etc.; and Tg1 is a group represented by the following general formula: (wherein Eg is a single bond or -N(Rg2)-, Rg1 and Rg2 each independently represent a hydrogen atom, an optionally substituted C1-6 alkyl group, etc. and Zg represents a C1-8 alkyl group, a C3-8 alicyclic hydrocarbon group, a C6-14 aryl group, etc.)], salts thereof or hydrates of the foregoing.
    由以下通式代表的化合物: [其中 Ag 是任选取代的 5 至 14 元杂环基团等;Xg 是-O-、-S-等;Yg 是任选取代的 C6-14 芳基、任选取代的 5 至 14 元杂环基团等;以及 Tg1 是由下通式表示的基团: (其中 Eg 是单键或-N(Rg2)-,Rg1 和 Rg2 各自独立地代表氢原子、任选取代的 C1-6 烷基等,Zg 代表 C1-8 烷基、C3-8 脂环烃基、C6-14 芳基等)]、其盐或上述物质的水合物。
  • AZAARENE DERIVATIVES
    申请人:Eisai Co., Ltd.
    公开号:EP1522540A1
    公开(公告)日:2005-04-13
    A compound represented by the general formula: wherein X1 represents a nitrogen atom or a group represented by the formula -CR10=; X2 represents a nitrogen atom or a group represented by the formula -CR11=; Y represents an oxygen atom or the like; R1 represents a C1-6 alkoxy group, an optionally substituted C6-10 aryloxy group, a group represented by the formula -NR12aR12b or the like; R2 represents a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like; R3, R4, R5, R6, R7, R8, R10 and R11 each independently represent a hydrogen atom, a halogen atom, an optionally substituted C1-6 alkyl group, or the like; R9 represents a group represented by the formula -NR16aR16b or the like; and R12a, R12b, R16a and R16b each independently represent a hydrogen atom, an optionally substituted C1-6 alkyl group, or the like, a salt thereof, or a hydrate of the foregoing.
    由通式代表的化合物: 其中 X1 代表氮原子或由式 -CR10= 代表的基团;X2 代表氮原子或由式 -CR11= 代表的基团;Y 代表氧原子或类似物;R1 代表 C1-6 烷氧基、任选取代的 C6-10 芳氧基、由式 -NR12aR12b 代表的基团或类似物;R2 代表氢原子、任选取代的 C1-6 烷基或类似物;R3、R4、R5、R6、R7、R8、R10 和 R11 各自独立地代表氢原子、卤原子、任选取代的 C1-6 烷基或类似物;R9 代表由式 -NR16aR16b 或类似物表示的基团;以及 R12a、R12b、R16a 和 R16b 各自独立地代表氢原子、任选取代的 C1-6 烷基或类似物、其盐或上述物质的水合物。
  • Process for the preparation of 4-phenoxy quinoline derivatives
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1777218A1
    公开(公告)日:2007-04-25
    The present invention concerns a process for preparing a compound represented by the following general formula (a-11): or a pharmacologically acceptable salt or hydrate thereof, which comprises reacting a compound represented by the following general formula (a-12): with a compound represented by the following general formula (a-4) : wherein the residues R1, R2, Rsa1 - Rsa3, R300, R301 and Z are as defined in the claims.
    本发明涉及一种制备由以下通式(a-11)代表的化合物的工艺: 或其药理学上可接受的盐或水合物的制备工艺,该工艺包括使下式通式(a-12)所代表的化合物反应: 与下式通式(a-4)所代表的化合物反应: 其中残基 R1、R2、Rsa1-Rsa3、R300、R301 和 Z 如权利要求中所定义。
查看更多